NCT00115206View on ClinicalTrials.gov

Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 2002

Study Completion Date

July 31, 2004

Conditions
Non-Small Cell Lung Cancer
Interventions
DRUG

Neulasta® (pegfilgrastim)

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY

NCT00115206 - Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy | Biotech Hunter | Biotech Hunter